HABA Laboratories,Inc. (TYO:4925)
1,717.00
-4.00 (-0.23%)
Aug 21, 2026, 3:30 PM JST
HABA Laboratories,Inc. Revenue
HABA Laboratories,Inc. had revenue of 2.53B JPY in the quarter ending June 30, 2026, a decrease of -3.92%. This brings the company's revenue in the last twelve months to 12.04B, up 0.16% year-over-year. In the fiscal year ending March 31, 2026, HABA Laboratories,Inc. had annual revenue of 12.14B with 0.66% growth.
Revenue (ttm)
12.04B
Revenue Growth
+0.16%
P/S Ratio
0.54
Revenue / Employee
23.02M
Employees
523
Market Cap
6.49B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 12.14B | 80.00M | 0.66% |
| Mar 31, 2025 | 12.06B | -263.00M | -2.13% |
| Mar 31, 2024 | 12.32B | 286.00M | 2.38% |
| Mar 31, 2023 | 12.04B | -870.00M | -6.74% |
| Mar 31, 2022 | 12.91B | -1.40B | -9.78% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Niitaka | 24.62B |
| SHOBIDO | 23.12B |
| Nippon Shikizai | 17.18B |
| Premier Anti-Aging | 14.25B |
| AXXZIA | 13.29B |
| Kitanotatsujin | 11.82B |
| Almado | 11.10B |
| Liberta | 10.66B |